PHK
QNCX icon

Point72 Hong Kong’s Quince Therapeutics QNCX Stock Holding History

Point72 Hong Kong’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19
Closed -$48K – 2246
2021
Q4 		$48K Buy
19
+14
+280% +$85.4K ﹤0.01% 1355
2021
Q3 		$91K Buy
5
+4
+400% +$63.6K ﹤0.01% 1374
2021
Q2 		$12K Hold
1
– – ﹤0.01% 1717
2021
Q1 		$7K Sell
1
-3
-75% -$21.6K ﹤0.01% 1625
2020
Q4 		$20K Buy
+4
New +$35.4K ﹤0.01% 1426

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's QNCX Position: Q1 2022 in Review

Point72 Hong Kong sold out of Quince Therapeutics (QNCX) in Q1 2022, closing a stake of 19 shares — an estimated $48K sold.

Point72 Hong Kong first reported a position in QNCX in Q4 2020 and held it in 5 quarters. The position peaked at $91K in Q3 2021. 85 funds tracked by Wall St. Rank hold QNCX as of Q1 2022.

  • Point72 Hong Kong reported no remaining Quince Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 19 Quince Therapeutics shares in Q1 2022, an estimated $48K.
  • Point72 Hong Kong first reported a position in Quince Therapeutics in Q4 2020 and held it in 5 quarters.
  • Point72 Hong Kong's Quince Therapeutics position peaked at $91K in Q3 2021.
  • 85 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.